While surgical excision remains the primary treatment method, systemic treatments such as PD-1 and CTLA-4 inhibitors, BRAF/MEK-targeted agents, and, in some cases, chemotherapy or radiation therapy play a crucial role in managing malignant melanoma. Here, CTLA4 is linked to melanoma.